ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

13
Analysis
Health CareUnited States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
bearishDoosan Robotics
30 Sep 2024 21:28

End of Mandatory Lock-Up Periods for 39 Companies in Korea in October 2024

We discuss the end of the mandatory lock-up periods for 39 stocks in Korea in October 2024, among which four are in KOSPI and 35 are in KOSDAQ.

Logo
382 Views
Share
30 Apr 2024 17:05

End of Mandatory Lock-Up Periods for 54 Companies in Korea in May 2024

We discuss the end of the mandatory lock-up periods for 54 stocks in Korea in May 2024, among which 4 are in KOSPI and 50 are in KOSDAQ.

Logo
371 Views
Share
bullishGigaVis
11 Jan 2024 19:35

An Early Look at the Potential KOSDAQ150 Rebalance Candidates in June 2024

In this insight, we discuss the potential KOSDAQ150 rebalance candidates in June 2024. Potential inclusion candidates include LS Materials,...

Logo
245 Views
Share
19 Feb 2018 10:27

Korean IPOs - Evidence-Based Analysis & The Whiplash Effect

In this report, we provide evidence-based analysis of using key criteria such as the IPO price determined at high/low end of the IPO price range...

Logo
168 Views
Share
21 Dec 2017 08:14

StubWorld - Set-Up & Unwind Extremes: AVIC, Kolon

This week I briefly look at: Avic International Holdings Ltd (161 HK), again, as investors take-profit while 69.7%-held subsidiary Shennan Circuits...

Logo
533 Views
Share
x